<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04758676</url>
  </required_header>
  <id_info>
    <org_study_id>KARIM-BIA-Ka21</org_study_id>
    <nct_id>NCT04758676</nct_id>
  </id_info>
  <brief_title>BIA Assessment of Polymyoneuropathy in Critically Ill Patients</brief_title>
  <official_title>Bioelectric Impedance Analysis (BIA) Assessment of Polymyoneuropathy in Critically Ill Patients as a Part of Post-ICU Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ostrava</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to monitor and evaluate changes in body composition, with a special&#xD;
      emphasis on muscle mass, in the context of polyneuromyopathy of critically-ill patients at&#xD;
      ICU, on artificial ventilation (duration of artificial ventilation at least 7 days), and&#xD;
      subsequent comparison with the patient's condition in 12 weeks, as a part of Post-Intensive&#xD;
      Care Syndrome (PICS) monitoring. The effect of the package (nutritional recommendations +&#xD;
      physiotherapy protocol vs. standard of care) will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intensive medicine keeps pushing its borders, and enables survival of critical illnesses,&#xD;
      including the substitution of organ functions in patients with multiple organ dysfunction&#xD;
      (MODS). Despite the improvements in short-term outcomes, the long-term prognosis and quality&#xD;
      of life (long-term outcomes) in patients, who survived a critical condition at ICU, remain&#xD;
      unfavorable. The long-term consequences may persist for months or even years.&#xD;
&#xD;
      Post-intensive care syndrome (PICS) represents a significantly limiting impairment in three&#xD;
      areas: physical (polyneuromyopathy of critically-ill patients), cognitive (delirium), and&#xD;
      mental (development of depressions and PTSD - post-traumatic stress disorder). It is&#xD;
      especially the rapid deterioration of muscles caused with the catabolic effect of the illness&#xD;
      itself during accentuated proteolysis, very negatively affects the muscle strength, inability&#xD;
      to discontinue artificial ventilation in the patient, increase of infections, and&#xD;
      prolongation of the ICU stay. It often results in the inability to discharge the patient into&#xD;
      home care. Polyneuromyopathy affects up to 40% of critically-ill patients; at the greatest&#xD;
      risk are especially patients in a serious catabolic state, with activated systemic&#xD;
      inflammatory response, with microvascular ischemia, on corticosteroids, immobilized, and on&#xD;
      long-term artificial ventilation. The prevention is difficult, as well as monitoring of the&#xD;
      lean body mass (LBM), especially in the muscle mass of critically ill patients, who are&#xD;
      further affected with changes in hydration and fluid leak.&#xD;
&#xD;
      BIA - bioelectric impedance is a non-invasive technique, which is able, on the basis of&#xD;
      impedance, to evaluate body composition (muscles, fat, total body fluid), determine hydration&#xD;
      (ratio of extracellular and intracellular fluid, fluid retention); another prognostic marker&#xD;
      is also the phase angle. It helps to evaluate markers of nutrition, basal energetic&#xD;
      metabolism.&#xD;
&#xD;
      The BIS Multiscan 5000 device measures 50 frequencies, which are used to create a Cole Plot,&#xD;
      using a mathematical model. It enables obtaining data from bed-ridden critically-ill&#xD;
      patients, using tetrapolar bioelectric impedance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 29, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>There are two arms in the study - experimental group (diagnostics with the Multiscan 5000 device, nutritional recommendations, physiotherapy protocol), and control group (standard of care)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking is used in the study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body composition will be studied using bioimpedance analysis - comparison of skeletal muscle mass, fats, body fluids</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the albumin level</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in the albumin level will be observed (in grams/Litre)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the prealbumin level</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in the prealbumin level will be observed (in milligrams/Litre)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the C-reactive protein (CRP) level</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in the C-reactive protein (CRP) level will be observed (in milligrams/Litre)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the presepsin level</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in the presepsin level will be observed (in picograms/millilitre)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of muscle functions</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of muscle functions will be performed using dynamometry.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Functional limitations - time up and go test (TUG)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Functional limitations will be assessed with TUG (time up and go test) (in seconds)</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional limitations - spirometry - forced vital capacity (FCV)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Functional limitations will be assessed with spirometry - forced vital capacity (FCV) (volume)</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional limitations - spirometry - forced expiratory velocity (FEV1)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Functional limitations will be assessed with spirometry - forced expiratory velocity in one second (FEV1) (velocity)</description>
  </other_outcome>
  <other_outcome>
    <measure>Cognitive state</measure>
    <time_frame>12 weeks</time_frame>
    <description>Cognitive state of study subjects will be assessed with the presence of post-traumatic stress disorder (PTSD)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sepsis</condition>
  <condition>Trauma</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Nutritional and physiotherapy protocol, BIA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study subjects randomized into this study arm will be indicated for nutritional and physiotherapy protocol, based upon the obtained results of the measurements, using bioimpedance analysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study subjects randomized into this study arm will be provided the current standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional and physiotherapy protocol, BIA</intervention_name>
    <description>Study subjects will be treated using the nutritional and physiotherapy protocol, based upon the results of measurements, using bioimpedance analysis.</description>
    <arm_group_label>Nutritional and physiotherapy protocol, BIA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Study subjects will receive the current standard of care.</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with respiratory insufficiency&#xD;
&#xD;
          -  Expected period of artificial ventilation of 7 days&#xD;
&#xD;
          -  Acute lung injury (ALI)&#xD;
&#xD;
          -  Acute respiratory distress syndrome (ARDS)&#xD;
&#xD;
          -  Acute exacerbation of chronic obstructive pulmonary disease (COPD)&#xD;
&#xD;
          -  Signed informed consent (may be signed by witnesses, if the patient is unconscious)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with unfavorable prognosis for 12-week follow-up&#xD;
&#xD;
          -  APACHE Score &gt;30&#xD;
&#xD;
          -  Metastasizing malignity&#xD;
&#xD;
          -  Patients after cardiopulmonary resuscitation (CPR) prior to admission&#xD;
&#xD;
          -  Cerebral edema&#xD;
&#xD;
          -  Cerebral trauma&#xD;
&#xD;
          -  Intracranial hypertension&#xD;
&#xD;
          -  Liver cirrhosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcela Káňová, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiří Hynčica</last_name>
    <phone>0042059737</phone>
    <phone_ext>2587</phone_ext>
    <email>jiri.hyncica@fno.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Ostrava, Department of Physiology and Patophysiology</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70300</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Petřeková, Mgr., Ph.D.</last_name>
      <phone>0042055346</phone>
      <phone_ext>1773</phone_ext>
      <email>karin.petrekova@osu.cz</email>
    </contact>
    <investigator>
      <last_name>Karin Petřeková, Mgr., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iva Chwalková, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>70852</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiří Hynčica</last_name>
      <phone>0042059737</phone>
      <phone_ext>2587</phone_ext>
      <email>jiri.hyncica@fno.cz</email>
    </contact>
    <investigator>
      <last_name>Marcela Káňová, MD,Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vojtěch Vodička, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Klára Rusková, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivana Nytra, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martina Stodůlková, DiS.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ján Šida, Mgr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>polymyoneuropathy</keyword>
  <keyword>bioelectric impedance</keyword>
  <keyword>post-intensive care syndrome</keyword>
  <keyword>multiple organ dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

